Danesi R - Search Results

1

Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.

Silvestris N, Del Re M, Azzariti A, Maiello E, Lombardi L, Cinieri S, Guarini A, Brunetti AE, Delcuratolo S, De Vita F, Pisconti S, Danesi R, Colucci G. Silvestris N, et al. Among authors: danesi r. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S111-7. doi: 10.1517/14728222.2011.652089. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443211 Review.

2

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.

Crea F, Giovannetti E, Zinzani PL, Danesi R. Crea F, et al. Among authors: danesi r. Crit Rev Oncol Hematol. 2009 Oct;72(1):21-44. doi: 10.1016/j.critrevonc.2008.10.014. Epub 2008 Dec 25. Crit Rev Oncol Hematol. 2009. PMID: 19111474 Review.

3

Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity.

Di Paolo A, Bocci G, Polillo M, Del Re M, Di Desidero T, Lastella M, Danesi R. Di Paolo A, et al. Among authors: danesi r. Curr Drug Metab. 2011 Dec;12(10):932-43. doi: 10.2174/138920011798062283. Curr Drug Metab. 2011. PMID: 21787264 Review.

4

Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.

Danova M, Barni S, Del Mastro L, Danesi R, Pappagallo GL. Danova M, et al. Among authors: danesi r. Expert Rev Anticancer Ther. 2011 Aug;11(8):1303-13. doi: 10.1586/era.11.72. Expert Rev Anticancer Ther. 2011. PMID: 21916584 Review.

5

Pharmacogenetics of anti-estrogen treatment of breast cancer.

Del Re M, Michelucci A, Simi P, Danesi R. Del Re M, et al. Among authors: danesi r. Cancer Treat Rev. 2012 Aug;38(5):442-50. doi: 10.1016/j.ctrv.2011.08.003. Epub 2011 Sep 13. Cancer Treat Rev. 2012. PMID: 21917382 Review.

6

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

Del Re M, Di Paolo A, van Schaik RH, Bocci G, Simi P, Falcone A, Danesi R. Del Re M, et al. Among authors: danesi r. EPMA J. 2010 Sep;1(3):495-502. doi: 10.1007/s13167-010-0041-2. Epub 2010 Jul 25. EPMA J. 2010. PMID: 23199091 Free PMC article.

7

Author's reply: To PMID 22443211.

Silvestris N, Brunetti AE, Guarini A, Del Re M, Danesi R, Cinieri S. Silvestris N, et al. Among authors: danesi r. Expert Opin Ther Targets. 2013 Apr;17(4):474-5. Expert Opin Ther Targets. 2013. PMID: 23610780 No abstract available.

8

Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature.

Tomisti L, Del Re M, Bartalena L, Tanda ML, Pucci A, Pambianco F, Danesi R, Braverman LE, Martino E, Bogazzi F. Tomisti L, et al. Among authors: danesi r. Endocr Pract. 2013 Nov-Dec;19(6):1043-9. doi: 10.4158/EP13093.RA. Endocr Pract. 2013. PMID: 23807523 Review.

9

Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.

Del Re M, Vasile E, Falcone A, Danesi R, Petrini I. Del Re M, et al. Among authors: danesi r. Expert Rev Mol Diagn. 2014 May;14(4):453-68. doi: 10.1586/14737159.2014.908120. Epub 2014 Apr 11. Expert Rev Mol Diagn. 2014. PMID: 24725257 Review.

10

Genetic variation: effect on prostate cancer.

Sissung TM, Price DK, Del Re M, Ley AM, Giovannetti E, Figg WD, Danesi R. Sissung TM, et al. Among authors: danesi r. Biochim Biophys Acta. 2014 Dec;1846(2):446-56. doi: 10.1016/j.bbcan.2014.08.007. Epub 2014 Sep 6. Biochim Biophys Acta. 2014. PMID: 25199985 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters